Jane Clapham

604 total citations
9 papers, 526 citations indexed

About

Jane Clapham is a scholar working on Immunology, Molecular Biology and Sensory Systems. According to data from OpenAlex, Jane Clapham has authored 9 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Sensory Systems. Recurrent topics in Jane Clapham's work include Mast cells and histamine (5 papers), Olfactory and Sensory Function Studies (4 papers) and Asthma and respiratory diseases (2 papers). Jane Clapham is often cited by papers focused on Mast cells and histamine (5 papers), Olfactory and Sensory Function Studies (4 papers) and Asthma and respiratory diseases (2 papers). Jane Clapham collaborates with scholars based in United Kingdom, New Zealand and United States. Jane Clapham's co-authors include Gavin J. Kilpatrick, Deborah Evans, Jason Brown, J. W. CLITHEROW, Ann G. Hayes, Jen Barnes, Paul Beswick, D. I. C. SCOPES, Celestine T. O’Shaughnessy and Julie C. Barnes and has published in prestigious journals such as PLoS ONE, British Journal of Pharmacology and European Journal of Pharmacology.

In The Last Decade

Jane Clapham

9 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Clapham United Kingdom 7 380 313 204 74 64 9 526
M. D. Cowart United States 9 261 0.7× 228 0.7× 117 0.6× 19 0.3× 54 0.8× 14 387
Sophie‐Pénélope Guenin France 9 212 0.6× 279 0.9× 68 0.3× 35 0.5× 169 2.6× 14 508
M. Detzner Germany 5 348 0.9× 268 0.9× 189 0.9× 10 0.1× 68 1.1× 6 427
Victoria A. Komater United States 10 158 0.4× 165 0.5× 84 0.4× 19 0.3× 29 0.5× 10 304
Carla Ferrada Spain 9 156 0.4× 363 1.2× 72 0.4× 8 0.1× 27 0.4× 9 506
Kiev S. Ly United States 8 199 0.5× 183 0.6× 20 0.1× 91 1.2× 32 0.5× 12 340
Christine Ouvry France 10 110 0.3× 270 0.9× 39 0.2× 14 0.2× 269 4.2× 11 490
Shuhei Horio Japan 11 149 0.4× 161 0.5× 11 0.1× 3 0.0× 22 0.3× 28 334
E. Boarato Italy 10 119 0.3× 246 0.8× 9 0.0× 7 0.1× 15 0.2× 13 436
Jian‐Nong Ma United States 10 42 0.1× 304 1.0× 7 0.0× 22 0.3× 13 0.2× 17 452

Countries citing papers authored by Jane Clapham

Since Specialization
Citations

This map shows the geographic impact of Jane Clapham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Clapham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Clapham more than expected).

Fields of papers citing papers by Jane Clapham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Clapham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Clapham. The network helps show where Jane Clapham may publish in the future.

Co-authorship network of co-authors of Jane Clapham

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Clapham. A scholar is included among the top collaborators of Jane Clapham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Clapham. Jane Clapham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lucero, Adam A., Donia Macartney‐Coxson, Jane Clapham, et al.. (2021). Effects of whey protein on skeletal muscle microvascular and mitochondrial plasticity following 10 weeks of exercise training in men with type 2 diabetes. Applied Physiology Nutrition and Metabolism. 46(8). 915–924. 6 indexed citations
2.
Macartney‐Coxson, Donia, Kirsty Danielson, Jane Clapham, et al.. (2020). MicroRNA Profiling in Adipose Before and After Weight Loss Highlights the Role of miR‐223‐3p and the NLRP3 Inflammasome. Obesity. 28(3). 570–580. 13 indexed citations
3.
Macartney‐Coxson, Donia, Alanna M. Cameron, Jane Clapham, & Miles C. Benton. (2020). DNA methylation in blood—Potential to provide new insights into cell biology. PLoS ONE. 15(11). e0241367–e0241367. 4 indexed citations
4.
Ren, Xiaoyun, David Eccles, Jane Clapham, et al.. (2017). Genomic, Transcriptomic, and Phenotypic Analyses of Neisseria meningitidis Isolates from Disease Patients and Their Household Contacts. mSystems. 2(6). 2 indexed citations
5.
CLITHEROW, J. W., Paul Beswick, D. I. C. SCOPES, et al.. (1996). Novel 1, 2, 4-oxadiazoles as potent and selective histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 6(7). 833–838. 88 indexed citations
6.
Clapham, Jane & Gavin J. Kilpatrick. (1994). Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse. European Journal of Pharmacology. 259(2). 107–114. 84 indexed citations
7.
Barnes, Julie C., et al.. (1993). Pharmacological activity of VUF 9153, an isothiourea histamine H3 receptor antagonist. European Journal of Pharmacology. 250(1). 147–152. 37 indexed citations
8.
Clapham, Jane & Gavin J. Kilpatrick. (1993). Histamine H3 receptor-mediated modulation of water consumption in the rat. European Journal of Pharmacology. 232(1). 99–103. 56 indexed citations
9.
Clapham, Jane & Gavin J. Kilpatrick. (1992). Histamine H3receptors modulate the release of [3H]‐acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3receptor subtypes. British Journal of Pharmacology. 107(4). 919–923. 236 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026